Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

April 5, 2023

Study Completion Date

December 31, 2025

Conditions
Carotid Atherosclerosis
Interventions
DIAGNOSTIC_TEST

Perflutren

The ultrasound contrast agent is used to improve the quality of ultrasound imaging and is infused over 5-10 minutes. The contrast agent consists of the gas-filled microbubbles smaller than the capillary size which circulate in the vascular system. The contrast agent is cleared from the body naturally within 30 minutes.

Trial Locations (1)

19107

Thomas jefferson University, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER